US2009264303A1PendingUtilityA1
Polypeptides having a functional domain of interest and methods of identifying and using same
Individually held — no corporate assignee on recordPriority: Apr 7, 1995Filed: May 21, 2007Published: Oct 22, 2009
Est. expiryApr 7, 2015(expired)· nominal 20-yr term from priority
C40B 30/04G01N 2500/04C40B 40/02G01N 33/6842A61K 38/00C12N 15/1037G01N 2500/02G01N 33/6845
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel polypeptides having functional domains of interest are described, along with DNA sequences that encode the same. A method of identifying these polypeptides by means of a sequence-independent (that is, independent of the primary sequence of the polypeptide sought), recognition unit-based functional screen is also disclosed. Various applications of the method and of the polypeptides identified are described, including their use in assay kits for drug discovery, modification, and refinement.
Claims
exact text as granted — not AI-modified1 . The method of identifying a polypeptide comprising a functional domain of interest comprising:
(a) contacting a multivalent recognition unit complex with a plurality of polypeptides; and (b) identifying a polypeptide having a selective binding affinity for said recognition unit complex.
2 . The method of claim 1 in which said plurality of polypeptides is from a polypeptide expression library.
3 . The method of claim 1 in which said plurality of polypeptides is obtained from a virus.
4 . The method of claim 2 in which said expression library is a cDNA expression library.
5 . The method of claim 2 in which said expression library is a genomic DNA library.
6 . The method of claim 2 in which said expression library is a recombinant bacteriophage library.
7 . The method of claim 6 in which said recombinant bacteriophage library is a recombinant M13 library.
8 . The method of claim 2 in which said expression library is a recombinant plasmid or cosmid library.
9 . The method of claim 1 in which the recognition unit is a peptide.
10 . The method of claim 1 in which said recognition unit is a peptide having less than about 140 amino acid residues.
11 . The method of claim 1 in which said recognition unit is a peptide having less than about 100 amino acid residues.
12 . The method of claim 1 in which said recognition unit is a peptide having less than about 70 amino acid residues.
13 . The method of claim 1 in which said recognition unit is a peptide having about 6 to 60 amino acid residues.
14 . The method of claim 1 in which said recognition unit is a peptide having 20 to 50 amino acid residues.
15 . The method of claim 1 in which the valency of the recognition unit in the complex is at least two.
16 . The method of claim 9 in which the valency of the recognition unit in the complex is at least two.
17 . The method of claim 1 in which the valency of the recognition unit in the complex is at least four.
18 . The method of claim 9 in which the valency of the recognition unit in the complex is at least four.
19 . The method of claim 17 in which the recognition unit complex is a complex comprising (a) avidin or streptavidin, and (b) biotinylated recognition units.
20 . The method of claim 18 in which the recognition unit complex is a complex comprising (a) avidin or streptavidin, and (b) the biotinylated peptides.
21 - 102 . (canceled)Join the waitlist — get patent alerts
Track US2009264303A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.